JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB40845

Anti-Glutamate receptor 3/GluA3 antibody [EP813Y]

Be the first to review this product! Submit a review

|

(22 Publications)

Rabbit Recombinant Monoclonal Glutamate receptor 3/GluA3 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 22 publications.

View Alternative Names

GluA3, GLUR3, GLURC, GRIA3, Glutamate receptor 3, GluR-3, AMPA-selective glutamate receptor 3, GluR-C, GluR-K3

5 Images
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
  • WB

Lab

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (ab40845) at 1/1000 dilution

All lanes:

Human hippocampus lysates at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 101 kDa

false

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
  • WB

Unknown

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)

All lanes:

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (ab40845) at 1/5000 dilution

All lanes:

human brain lysate at 10 µg

Predicted band size: 101 kDa

Observed band size: 95 kDa

false

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
  • WB

Lab

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (ab40845) at 1/2000 dilution

Lane 1:

Mouse hippocampus lysates at 20 µg

Lane 2:

Rat brain lysates at 20 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/2000 dilution

Predicted band size: 101 kDa

Observed band size: 100 kDa

false

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
  • WB

Lab

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)

Blocking and diluting buffer and concentration : 5% NFDM/TBST

In Western blot, Anti-Myc tag antibody [9E10] - Loading Control (ab32) staining at 1/10000 dilution.

This antibody does not cross-react with Human GRIA1,GRIA2 and GRIA4.

Exposure time : ab40845 : 40s, ab32 : 80s.

All lanes:

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (ab40845) at 1/1000 dilution

Lane 1:

293T transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate at 20 µg

Lane 2:

293T transfected with Human fragment GRIA2 expression vector containing a c-term myc-His-tag®, whole cell lysate at 20 µg

Lane 3:

293T transfected with Human full length GRIA3 expression vector containing a n-term myc-His-tag®, whole cell lysate at 20 µg

Lane 4:

293T transfected with human full length GRIA4 expression vector containing a c-term myc-His-tag®, whole cell lysate at 20 µg

Lane 5:

Recombinant Human full length GRIA1 Protein containing a C-Myc/DDK tag at 100 ng

Secondary

Lanes 1 - 5:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Lanes 1 - 5:

Goat anti-mouse IgG (H+L), Peroxidase conjugated at 1/10000 dilution

Observed band size: 100 kDa

false

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
  • WB

CiteAb

Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)

Glutamate receptor 3/GluA3 western blot using anti-Glutamate receptor 3/GluA3 antibody [EP813Y] ab40845. Publication image and figure legend from Adotevi, N. K. & Leitch, B., 2018, Front Mol Neurosci, PubMed 29311821.

ab40845 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab40845 please see the product overview.

Relative synaptic expression of GluA1–4 in the somatosensory cortex. (A–D) Representative immunoblots showing extrasynaptic and synaptic AMPAR subunit expression; (A) GluA1, (B) GluA2, (C) GluA3 and (D) GluA4, with the loading markers PSD95 and Pan-cadherin. (E) Scatter-plot with bar graphs showing a significant decrease in AMPAR GluA1 (0.79 ± 0.07, n = 6, p < 0.05), GluA2 (0.77 ± 0.08, n = 5, p < 0.05), GluA3 (0.77 ± 0.06, n = 7, p < 0.05), GluA4 (0.66 ± 0.02, n = 5, p < 0.01) expression in stargazer (E) synaptic fractions relative to NE control littermates after normalization against Pan-cadherin. Symbols '*' indicate p value significant digits (*p < 0.05, ***p < 0.005).

false

  • Carrier free

    Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP813Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody does not cross-react with Human GRIA1, GRIA2 and GRIA4.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Glutamate receptor 3 also known as GluA3 or GRIA3 is an ionotropic receptor that mediates fast excitatory synaptic transmission in the central nervous system. It is part of the AMPA receptor family and has a molecular mass of approximately 100 kDa. This receptor predominantly localizes in the brain where it plays a significant role in the mediation of glutamate neurotransmission influencing synaptic plasticity and communication among neurons. Its expression is vital for transmitting signals across excitatory synapses affecting learning and memory processes.
Biological function summary

GluA3 operates as a subunit of AMPA receptors forming tetrameric complexes that facilitate synaptic signal transmission. These channels permit the influx of sodium and to a lesser extent calcium ions when activated by the neurotransmitter glutamate. The interaction of GluA3 with auxiliary proteins like transmembrane AMPA receptor regulatory proteins (TARPs) can modulate its function and trafficking. As an essential component of synaptic transmission GluA3 influences synaptic strength and is involved in various neuronal activities.

Pathways

GluA3 plays an important role in synaptic plasticity and long-term potentiation (LTP). Two important pathways associated with GluA3 are the mitogen-activated protein kinase (MAPK) pathway and the calcium/calmodulin-dependent protein kinase II (CaMKII) pathway. The regulation of these pathways through GluA3 modulation affects synaptic efficacy and memory formation. GluA3 interacts with proteins like PSD-95 which influences receptor assembly and synapse structure integrating into broader signaling networks that govern cellular responses and adaptations.

GluA3 has been linked to neurodegenerative diseases and psychiatric disorders. Alterations in GluA3 expression or function are associated with Alzheimer's disease where disrupted glutamatergic signaling contributes to cognitive decline. Additionally GluA3 plays a role in schizophrenia where AMPA receptor dysfunction affects neural circuitry and synaptic plasticity. In these contexts GluA3 often interacts with proteins like NMDA receptors where their combined dysfunction can lead to imbalances in excitatory-inhibitory signaling exacerbating disease symptoms.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Ionotropic glutamate receptor that functions as a ligand-gated cation channel, gated by L-glutamate and glutamatergic agonists such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualic acid, and kainic acid (By similarity). L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system and plays an important role in fast excitatory synaptic transmission by inducing long-term potentiation (By similarity). Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse upon entry of calcium (PubMed : 17989220). The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist (PubMed : 17989220). In the presence of CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate (PubMed : 21172611).
See full target information GRIA3

Publications (22)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in molecular neuroscience 18:1635852 PubMed40771360

2025

Chronic reduction of synaptic proteins in the epileptogenic lesion of patients with hippocampal sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Akiko Oota-Ishigaki,Nami Suzuki,Keiya Iijima,Yutaro Takayama,Yuiko Kimura,Kotaro Hattori,Masaki Iwasaki,Takashi Hayashi

Physiological reports 11:e15673 PubMed37078449

2023

Altered expression of synaptic proteins and adhesion molecules in the hippocampus and cortex following the onset of diabetes in nonobese diabetic mice.

Applications

Unspecified application

Species

Unspecified reactive species

Takumi Yokokawa,Kohei Kido,Koji Sato,Tatsuya Hayashi,Satoshi Fujita

The European journal of neuroscience 55:18-31 PubMed34902209

2021

Hippocampal AMPA- and NMDA-induced cGMP signals are mainly generated by NO-GC2 and are under tight control by PDEs 1 and 2.

Applications

Unspecified application

Species

Unspecified reactive species

Jan Giesen,Evanthia Mergia,Doris Koesling,Michael Russwurm

Molecular and cellular biochemistry 477:191-203 PubMed34652536

2021

Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.

Applications

Unspecified application

Species

Unspecified reactive species

Min-Jie Hu,Mei Long,Rong-Juan Dai

Molecular therapy. Nucleic acids 26:773-786 PubMed34729247

2021

circ-NOL10 regulated by MTDH/CASC3 inhibits breast cancer progression and metastasis via multiple miRNAs and PDCD4.

Applications

Unspecified application

Species

Unspecified reactive species

Yujie Cai,Xing Zhao,Danze Chen,Fan Zhang,Qiuyang Chen,Chang-Chun Shao,Yan-Xiu Ouyang,Jun Feng,Lili Cui,Min Chen,Jianzhen Xu

The European journal of neuroscience 54:6237-6255 PubMed34390052

2021

Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Amanda L Wright,Paul A Della Gatta,Sheng Le,Britt A Berning,Prachi Mehta,Kelly R Jacobs,Hossai Gul,Rebecca San Gil,Thomas J Hedl,Winonah R Riddell,Owen Watson,Sean S Keating,Juliana Venturato,Roger S Chung,Julie D Atkin,Albert Lee,Bingyang Shi,Catherine A Blizzard,Marco Morsch,Adam K Walker

Neuroendocrinology 112:493-509 PubMed34348318

2021

N-Cadherin Regulates GluA1-Mediated Depressive-Like Behavior in Adolescent Female Rat Offspring following Prenatal Stress.

Applications

Unspecified application

Species

Unspecified reactive species

Shuya Shao,Dan Yao,Senya Li,Jing Li,Yufang Si,Huiping Zhang,Zhongliang Zhu,Dongli Song,Hui Li

Proceedings of the National Academy of Sciences of the United States of America 118: PubMed33593893

2021

Cognitive aging is associated with redistribution of synaptic weights in the hippocampus.

Applications

Unspecified application

Species

Unspecified reactive species

Eric W Buss,Nicola J Corbett,Joshua G Roberts,Natividad Ybarra,Timothy F Musial,Dina Simkin,Elizabeth Molina-Campos,Kwang-Jin Oh,Lauren L Nielsen,Gelique D Ayala,Sheila A Mullen,Anise K Farooqi,Gary X D'Souza,Corinne L Hill,Linda A Bean,Annalise E Rogalsky,Matthew L Russo,Dani M Curlik,Marci D Antion,Craig Weiss,Dane M Chetkovich,M Matthew Oh,John F Disterhoft,Daniel A Nicholson

Journal of the American Heart Association 9:e015487 PubMed32306814

2020

Smad3 Regulates Neuropilin 2 Transcription by Binding to its 5' Untranslated Region.

Applications

Unspecified application

Species

Unspecified reactive species

Xiujie Xie,Go Urabe,Lynn Marcho,Corey Williams,Lian-Wang Guo,K Craig Kent

The Journal of clinical investigation 129:3864-3876 PubMed31424425

2019

TMEM25 modulates neuronal excitability and NMDA receptor subunit NR2B degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Haiqing Zhang,Xin Tian,Xi Lu,Demei Xu,Yi Guo,Zhifang Dong,Yun Li,Yuanlin Ma,Chengzhi Chen,Yong Yang,Min Yang,Yi Yang,Feng Liu,Ruijiao Zhou,Miaoqing He,Fei Xiao,Xuefeng Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com